SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001599298-24-000076
Filing Date
2024-04-25
Accepted
2024-04-25 17:03:43
Documents
4
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A summittherapeuticsinc-2024.htm DEF 14A 551234
2 image.jpg GRAPHIC 12465
3 summittherapeuticsinc_vxpr.jpg GRAPHIC 520968
4 summittherapeuticsinc_vxpra.jpg GRAPHIC 232698
  Complete submission text file 0001599298-24-000076.txt   1607284
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36866 | Film No.: 24877340
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)